What did @chasvitalityrx actually say?
The creator warned that testosterone replacement therapy causes blood to thicken, forces regular blood donations, and amounts to a "lifetime subscription to the Red Cross blood drive." The framing is deliberately alarming: TRT clinics are hiding this, Reddit hormone experts aren't telling you, and missing a donation risks "serious health problems." The video centers on a patient who supposedly had no idea he needed hematocrit monitoring after two years on therapy.
To be fair, the core issue is real. Erythrocytosis, meaning an abnormal rise in red blood cell production, is a documented side effect of testosterone therapy. The problem is how this creator talks about it. Every sentence is dialed to maximum dread. "His blood was thicker than a milkshake" is a memorable line, but it tells you nothing about actual clinical thresholds, how common this outcome is, or what properly managed care looks like.
Does the science back this up?
Partially, yes. Testosterone does stimulate erythropoiesis, meaning it raises red blood cell production, which raises hematocrit. That is not disputed. The clinical question is how often this becomes a real problem and how serious it is.
A 2023 review by Thirumalai et al. in The Journal of Clinical Endocrinology and Metabolism found that erythrocytosis (hematocrit above 54%) occurs in roughly 11 to 38% of men on injectable testosterone, with rates varying significantly by formulation, dose, and individual baseline. Injectable forms carry higher risk than gels or patches because they produce larger peaks in testosterone concentration. The TRAVERSE trial, published in 2023 in the New England Journal of Medicine, found that TRT did not significantly increase major cardiovascular events, but it did show a higher incidence of pulmonary embolism and erythrocytosis in the testosterone group compared to placebo. So the risk is documented, but it is not the universal catastrophe this video implies.
The creator's claim that some men must donate blood "as much as every eight weeks" is plausible in high-dose or poorly managed cases, but presenting this as routine or inevitable is inaccurate.
What did they get wrong (or right)?
They got the mechanism right. Testosterone increases red blood cell production. Blood viscosity rises. The heart works harder under elevated hematocrit. These are real physiological facts, not invented scare tactics.
What they got wrong is the framing of inevitability. The creator presents erythrocytosis as something that will happen and will require mandatory blood donations, with no acknowledgment that dose adjustments, formulation changes, or switching delivery methods can resolve elevated hematocrit in many patients without any blood donation at all. A 2021 study by Fernandez-Balsells et al. in Annals of Internal Medicine noted that erythrocytosis often responds to dose reduction before therapeutic phlebotomy becomes necessary.
The anecdote about the patient who "had no idea" about hematocrit monitoring is used to indict all TRT clinics. That patient's experience may reflect genuinely poor care, but using one data point to characterize an entire category of healthcare providers is not analysis. It is storytelling designed to generate anxiety. The creator also mispronounces both "hematocrit" (as "maticrit") and "testosterone" (as "test-astroded"), which does not inspire confidence in their clinical expertise.
What should you actually know?
If you are on TRT or considering it, hematocrit monitoring is standard of care, not optional. The Endocrine Society's clinical practice guidelines recommend checking hematocrit at baseline, at three to six months, and annually once stable. If hematocrit exceeds 54%, clinicians are expected to act, whether that means reducing dose, changing formulation, or in some cases, therapeutic phlebotomy.
Blood donation is one management tool, not an inevitable sentence. Many patients on well-managed TRT protocols never develop clinically significant erythrocytosis. The creator's assertion that this is something "clinics hide" conflicts with the fact that it appears in every major endocrinology guideline and package insert for testosterone products.
If your provider has never discussed hematocrit with you, that is a legitimate concern worth raising. But the answer is not to avoid TRT out of fear. It is to find a provider who follows established monitoring protocols.